An accelerated research program helped Aussie export Axon Instruments (ASX:AXN) drive sales up 25 per cent last year, but also contributed to a significant profit slump. [ + ]

Australia's first publicly-listed pure genomics research company, Bionomics Ltd, has interested a second northern hemisphere partner in its portfolio of patented genes. [ + ]

Bioengineering group Eiffel Technologies (ASX: EIF) has posted a more than three per cent fall in after-tax profits to $777,000 for the second half of last year. [ + ]

The SIA's National Council met in Melbourne on 21 February to decide on the association's goals for 2002. The SIA workplan for 2002 has been developed around the theme of 'inform, involve, influence'.

Two important reports highlighting the key role of photonics to Australia's economic future have been launched by the Minister for Communications, IT and the Arts, Senator Richard Alston.

Small particle technology company Sirtex Medical is seeking European approval for its liver cancer treatment, following last week's announcement it had been approved by the US Food and Drug Administration. [ + ]

Adelaide biotechnology company BresaGen (ASX: BGN) has joined a Canadian imaging technology consortium to help fast-track its therapeutic stem cell delivery program. [ + ]

Mr Kevin Andrews, the Federal Minister for Ageing, has denied reports cabinet has reached a decision to ban embryonic stem cell research.

Bioinformatics, biotech and nanotechnology companies seeking venture capital funding may have to look elsewhere, according to speakers at the Silicon Alley Breakfast Club (SABC) meeting held in New York last week (March 7). [ + ]

Stanford University scientists have come up with a screen saver that uses thousands of idle computers to assist with simulations of protein folding. [ + ]

A government committee set up to assess Victoria's platform technology needs is expected to report its findings by mid-year. [ + ]

A surprise finding by a team of Adelaide scientists has provided the first evidence that the same gene on the X-chromosome may be responsible for some forms of both epilepsy and intellectual disability. [ + ]

The golden reach of a US philanthropist has touched the Queensland Institute of Medical Research again. [ + ]

A Bill dealing with the use of gene technologies and their products in the ACT has been tabled in the Legislative Assembly. The Gene Technology Bill 2000, was tabled by Chief Minister Jon Stanhope.

Fresh from inking pacts with two drug development companies, marine toxin specialist Xenome Ltd is on the verge of finalising many more similar deals, says CEO Tony Evans. [ + ]